Active
Pharmaceutical
Ingredients (APIs)
| Products | Pharmacopoeia | Therapeutic Category | Documents Availability |
|---|---|---|---|
| Dobutamine Hydrochloride | Ph.Eur / USP / IP | Cardiovascular | CEP |
| Trimetazidine Dihydrochloride | Ph. Eur / IP | Cardiovascular | CEP |
| Pentosan Polysulfate Sodium | In-house (ICH) | Interstitial Cystitis | USDMF |
| Tramadol Hydrochloride | Ph.Eur / USP / BP / IP | Analgesic | CEP / USDMF / KDMF / JDMF / Canada DMF |
| Lamotrigine | Ph. Eur./USP/IP | Anticonvulsant | CEP |
| Ezetimibe | In-house/USP/IP | Antihyperlipidemic | ODMF |
| Carvedilol | Ph. Eur | Antihypertensive | JDMF |
| Nebivolol Hydrochloride | In-House (ICH) / IP | Antihypertensive | DMF (ODMF) |
| Moxifloxacin Hydrochloride | Ph.Eur / USP / BP / IP | Antibiotic | CEP / WHO APIMF |
| Linezolid (Form-II) | In-House (ICH) / USP / IP | Antibiotic | ODMF |
| Teneligliptin Hydrobromide | In-House | Antidiabetic | ODMF |
| Etoricoxib | In-house/ IP | Anti-Inflammatory | ODMF |
| Fingolimod Hydrochloride | USP | Multiple Sclerosis | ODMF |
| Under development APIs | |||
| Rivaroxaban | Anticoagulant | Tech pack | |
| Tadalafil | Erectile Dysfunction(ED) | Tech pack | |
Disclaimer: Products covered by valid patents in any country
are not offered or
supplied to those
countries.
The customer should verify the patent position in the concerned
country.
